• TriHex Technology® – A blend of active peptides and key ingredients that works with the skin to help clear out damaged elastin and collagen and support the skin’s natural ability to produce new, healthy elastin and collagen.
• ChromaFADE Technology® - helps accelerate recovery from injectable treatments and enhances the overall appearance of skin*
• Ledum (Marsh Tea or Wild Rosemary) & Arnica Montana Extract - calms the skin and reduces appearance of redness and swelling.
• Hydroxymethoxyphenyl Decanone, Silver Mushroom, Sodium Hyaluronate, Hexapeptide-38 - supports natural hyaluronic acid levels resulting in improved skin plumpness and moisturization and healthy adipose tissue resulting in more youthful volume./li>

*Data on file at ALASTIN Skincare®

• Following injectable treatment, squeeze a small amount of serum on
  the cooling applicator tip and apply directly on and around the
  injection area. Repeat this application process 4 times daily, until the
  tube is empty.
  
• If using other skincare products post-treatment, apply INhance
  Post-Injection Serum on cleansed skin first, then follow with any
  additional serums, eye cream, moisturizer and SPF.
  

The Proof: 90% Increase in Elastic Fibers

Production of collagen begins to decline at age 20-25, and production of elastin slows to a trickle by age 40.



TriHex Technology® is formulated with Tripeptide-1 and Hexapeptide-12 to support the stimulation of both.



See the transformation below the skin’s surface using TriHex
Technology®. The deep blue fibers in the photo on the right show brand
new elastin fibers underneath the skin’s surface, supported by the
application of INhance Post-Injection Serum with TriHex Technology®.

Right forearm—40-yr-old female pretreatment (A) and 2
wk post-application of Tripeptide/Hexapeptide (INhance with TriHex
Technology, Alastin Skincare, Inc) Movat stain 40X-Left panel compared
to right: 90% increase in elastic fibers. 1 Reference: Widgerow, AD,
Napekoski, K. New approaches to skin photodamage
histology—Differentiating 'good' versus 'bad' Elastin. J Cosmet
Dermatol. 2021; 20: 526– 531. https://doi.org/10.1111/jocd.13865 2
Reference: Widgerow AD, Jacob C, Palm M, Garruto J, Bell M. Developing a
Topical Adjunct to Injectable Procedures. J Drugs Dermatol. 2020;19(4) 3
Individual Results May Vary